β2 and PT aPL were reported to cause LA (1) via direct interaction of β2 aPL with FV and activation by FXa and (2) via PT aPL competition with FXa for PL binding sites [65], actions which may account for the higher prevalence of LA described in patients with COVID-19 [13]. The gene discussed is F10; the disease is COVID-19.